Considerations on the clinical application of the human papillomavirus vaccine in Spain

Hum Vaccin. 2011 May;7(5):585-9. doi: 10.4161/hv.7.5.14817. Epub 2011 May 1.


The circumstances that in the opinion of the authors influence the lower than expected uptake of the vaccine against human papillomavirus in Spain are analyzed. Among others, aspects related to doubts about efficacy and safety, the attitude of the Spanish health authorities or the role of media and the antivaccine groups, as well as the vaccination "culture" of the gynecologist, are discussed. The authors conclude that only with the coordinated effort of all involved bodies in the vaccination process (health authorities, scientific societies, social agents, media...) wide coverage of HPV vaccine will be achieved.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Attitude of Health Personnel
  • Female
  • Health Policy
  • Humans
  • Middle Aged
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / administration & dosage*
  • Papillomavirus Vaccines / adverse effects
  • Papillomavirus Vaccines / immunology*
  • Patient Acceptance of Health Care / statistics & numerical data
  • Spain / epidemiology
  • Vaccination
  • Young Adult


  • Papillomavirus Vaccines